Mechanical thrombectomy in acute ischemic stroke: Consensus statement by ESO-Karolinska Stroke Update 2014/2015, supported by ESO, ESMINT, ESNR and EAN
@article{Wahlgren2016MechanicalTI, title={Mechanical thrombectomy in acute ischemic stroke: Consensus statement by ESO-Karolinska Stroke Update 2014/2015, supported by ESO, ESMINT, ESNR and EAN}, author={Nils Wahlgren and Tiago Prazeres Moreira and Patrik Michel and Thorsten Steiner and Olav Jansen and Christophe Cognard and Heinrich P. Mattle and Wim H. van Zwam and Staffan Holmin and Turgut Tatlisumak and Jesper Petersson and Valeria Caso and Werner Hacke and Mikael Mazighi and Marcel Arnold and Urs Fischer and Istv{\'a}n Szikora and Laurent Pierot and Jens Fiehler and Jan Gralla and Franz Fazekas and Kennedy R. Lees}, journal={International Journal of Stroke}, year={2016}, volume={11}, pages={134 - 147}, url={https://api.semanticscholar.org/CorpusID:16771319} }
The original version of this consensus statement on mechanical thrombectomy was approved at the European Stroke Organisation (ESO)-Karolinska Stroke Update conference in Stockholm, 16–18 November…
340 Citations
European Stroke Organisation (ESO)- European Society for Minimally Invasive Neurological Therapy (ESMINT) guidelines on mechanical thrombectomy in acute ischemic stroke
- 2019
Medicine
High quality evidence is found to recommend Mechanical thrombectomy plus best medical management (BMM) to improve functional outcome in patients with LVO related acute ischemic stroke within 6 hours after symptom onset.
No space left for intravenous thrombolysis in acute stroke: PROS
- 2016
Medicine
Patients with suspected large-artery occlusion and deemed candidates for thrombectomy, should be treated at a Comprehensive Stroke Centre with 24/7 endovascular treatment services, supporting the concept of centralization of intra-arterial thrombolysis resources and expertise.
European Stroke Organisation (ESO) – European Society for Minimally Invasive Neurological Therapy (ESMINT) Guidelines on Mechanical Thrombectomy in Acute Ischaemic StrokeEndorsed by Stroke Alliance for Europe (SAFE)
- 2019
Medicine
High quality evidence to recommend MT plus best medical management (BMM, including intravenous thrombolysis whenever indicated) to improve functional outcome in patients with LVO-related acute ischaemic stroke within 6 hours after symptom onset is found.
2019 Update of the Korean Clinical Practice Guidelines of Stroke for Endovascular Recanalization Therapy in Patients with Acute Ischemic Stroke
- 2019
Medicine
The clinical practice guidelines for ERT in patients with acute LAO in Korea are revised, intended to help healthcare providers, patients, and their caregivers make well-informed decisions and to improve the quality of care regarding ERT.
2019 Update of the Korean Clinical Practice Guidelines of Stroke for Endovascular Recanalization Therapy in Patients with Acute Ischemic Stroke
- 2019
Medicine
The clinical practice guidelines for ERT in patients with acute LAO in Korea are revised, intended to help healthcare providers, patients, and their caregivers make well-informed decisions and to improve the quality of care regarding ERT.
Thrombectomy in acute ischemic stroke: estimations of increasing demands
- 2016
Medicine
The need for policymakers and healthcare professionals to prepare for the increasing demands for advanced endovascular stroke treatment is highlighted, and there may be a substantial increase in demand for thrombectomies.
A New Era in Acute Ischaemic Stroke Treatment: A Review of UK and European Thrombectomy Guidelines
- 2016
Medicine
A systematic review of the new trials that compare thrombectomy to best medical-care created a new protocol which encompasses the trial results and European recommendations, in the hope to assist physicians worldwide.
European recommendations on organisation of interventional care in acute stroke (EROICAS)
- 2016
Medicine
The benefit of EVT is considered established since all five RCTs showed consistent benefit ofEVT over optimal medical management alone, and a dose–effect relation (reperfusion rates vs. clinical outcome).
European Recommendations on Organisation of Interventional Care in Acute Stroke (EROICAS)
- 2016
Medicine
The benefit of EVT is considered established since all fiveRCTs showed consistent benefit ofEVT over optimal medical management alone, and a dose–effect relation (reperfusion rates vs. clinical outcome).
Mechanical Thrombectomy for Acute Ischemic Stroke in Czech Republic: Technical Results from the Year 2016
- 2018
Medicine
Despite achieved good overall results, a great variability in some of the analyzed key time intervals among individual centers performing MT warrants further quality improvement.
72 References
Endovascular treatment for acute ischemic stroke.
- 2013
Medicine
When the value of perfusion imaging is addressed in a population in which neither of the treatment methods under study appears to work, the validity of the entire study may be questionable, and neither the authors of the MR RESCUE study nor Chimowitz,5 in the corresponding editorial, addresses this threat to the generalizability of the results.
Mechanical thrombectomy in acute ischemic stroke—experience from 6 years of practice
- 2014
Medicine
The results supports that mechanical thrombectomy is a safe and effective method to restore blood flow in selected patients suffering from an acute ischemic stroke.
Improved Clinical Outcome after Acute Basilar Artery Occlusion since the Introduction of Endovascular Thrombectomy Devices
- 2013
Medicine
Especially in patients with BAO - where endovascular treatment strategies are common clinical practice - bridging protocols with rtPA and modern thrombectomy devices should be used more frequently.
The Penumbra system for mechanical thrombectomy in endovascular acute ischemic stroke therapy
- 2012
Medicine
The Penumbra aspiration system is an effective tool to safely revascularize large-vessel occlusions in patients within 8 hours of onset of acute ischemic stroke who are either refractory to or excluded from IV thrombolytic therapy.
Thrombectomy within 8 hours after symptom onset in ischemic stroke.
- 2015
Medicine
Among patients with anterior circulation stroke who could be treated within 8 hours after symptom onset, stent retriever thrombectomy reduced the severity of post-stroke disability and increased the rate of functional independence.
Prospective, Multicenter, Single-Arm Study of Mechanical Thrombectomy Using Solitaire Flow Restoration in Acute Ischemic Stroke
- 2013
Medicine
In this single-arm study, treatment with the Solitaire Flow Restoration device in intracranial anterior circulation occlusions results in high rates of revascularization, low risk of clinically relevant procedural complications, and good clinical outcomes in combination with low mortality at 90 days.
Mechanical Thrombectomy with Stent Retrievers in Acute Basilar Artery Occlusion
- 2014
Medicine
Application of self-expanding retrievable stents in acute basilar artery occlusion resulted in a high recanalization rate without procedural complications and good clinical outcome in one-third of patients.
Mechanical thrombectomy as the primary treatment for acute basilar artery occlusion: experience from 5 years of practice
- 2012
Medicine
The study suggests that mechanical thrombectomy is a method distinct from therapies based on thrombolysis and that any randomized clinical trial on treatment for acute basilar occlusion must consider mechanical thROMbectomy as a separate entity.
Impact of Age and Baseline NIHSS Scores on Clinical Outcomes in the Mechanical Thrombectomy Using Solitaire FR in Acute Ischemic Stroke Study
- 2014
Medicine
SPAN-100 was an independent predictor of favorable outcome after adjusting for time to treatment and the extent of preintervention tissue damage according to the Alberta Stroke Program Early CT Score.
Endovascular treatment for acute ischemic stroke patients: implications and interpretation of IMS III, MR RESCUE, and SYNTHESIS EXPANSION trials: A report from the Working Group of International Congress of Interventional Neurology.
- 2014
Medicine
The results do not support a large magnitude benefit of endovascular treatment in subjects randomized in all the three trials, and large magnitude benefits can be expected with implementation of "parameter optimized endov vascular treatment" in patients with ischemic stroke who are candidates for IV thrombolytics.